The fact that BNO got the drug back speaks volumes about how the deal was originally structured
Spot on DDD 100% agree there. There was a paucity of information made available at the time and yes, all the evidence to date is that this will be a blockbuster if it passes muster, which I and apparently you believe it will. This will be a step-change in treatment paradigms imo without the long-term side-effects and other things (sedation, additive impairment of judgement etc,metabolic effects) that the benzos and other classes of drugs like the SSRIs, NSRIs, and the off-label use of newer atypicals, cannot get away from.
I'm not saying it'll suit all, that's unrealistic, but it would logically be the first-line drug in treatment of anxiety, all else being equal. But from what I can tell, your knowledge base already accounts for that.
Didn't mean to be rude with my comment, btw, you got me there!!
Can't wait for the CVC nonsense to be out of the way and back to full focus on development of our pipeline.
Cheers
BNO Price at posting:
30.5¢ Sentiment: Hold Disclosure: Held
